Entity > Corporation > US > New York City New York > Rvl Pharmaceuticals Plc
About Rvl Pharmaceuticals Plc
RVL Pharmaceuticals is a specialty pharmaceutical company specialising in the development and commercialization of ophthalmic and medical aesthetics products. The first FDA-approved ophthalmic product is the foundation of our unwavering commitment to improving patients' lives.
Focus on Eyecare and Medical Aesthetics: RVL Pharmaceuticals specializes in the development and commercialization of products in the eyecare and medical aesthetics sectors. The company aims to address the specific needs of these markets by offering innovative solutions.
Commercialization of UPNEEQ®: RVL Pharmaceuticals plc is primarily focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride). UPNEEQ® is a product that targets certain eye conditions and is used to treat symptoms such as redness and irritation.
Strategic Partnership with Revision Skincare®: In 2022, RVL Pharmaceuticals announced a strategic partnership with Revision Skincare®. This partnership aims to leverage the strengths of both companies to enhance the commercialization of UPNEEQ® and provide comprehensive skincare solutions.
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Rvl Pharmaceuticals Plc
| Company Attribute | Value |
| Address | StreetAddress: 400 Crossing Blvd, AddressLocality: Bridgewater, AddressRegion: New Jersey, PostalCode: 8807, AddressCountry: United States |
| Name | Rvl Pharmaceuticals Plc |
| Number Of Employees | 156 |
| Revenue | $17,501,000 USD |
| Url | rvlpharma |
Rvl Pharmaceuticals Plc
New York City, US
20 Sep 2023
Rvl Pharmaceuticals Plc
RVL Pharmaceuticals PLC (Pharmaceutical company)
RVL Pharmaceuticals plc (formerly Osmotica Pharmaceuticals plc) is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas.
-
Stock price : RVLP (NASDAQ) $0.12 0.00 (-4.05%)Sep 19, 4:00 PM EDT - Disclaimer
-
Subsidiaries : RVL Pharmaceuticals, Inc, Osmotica Pharmaceutical US LLC, Osmotica Holdings S.C.Sp.
-
Headquarters : Bridgewater, NJ
| Entity Home | Kalicube Pro Entity Page |